Evidence map›Paper›PMID 39773289›Full record

ArticleJournal of translational medicine2025

Safety and efficacy of mesenchymal stromal cells mitochondria transplantation as a cell-free therapy for osteoarthritis.

Ana Maria Vega-Letter, Cynthia García-Guerrero, Liliana Yantén-Fuentes, Carolina Pradenas, Yeimi Herrera-Luna, Eliana Lara-Barba, Felipe A Bustamante-Barrientos, Masyelly Rojas, María Jesús Araya, Nicole Jeraldo and 26 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Ana Maria Vega-Letter *Escuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Cynthia García-Guerrero *Center of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Liliana Yantén-FuentesCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Carolina PradenasCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Yeimi Herrera-LunaCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Eliana Lara-BarbaCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Felipe A Bustamante-BarrientosCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Masyelly RojasCentro de Investigación e Innovación Biomédica, Facultad de Medicina, Universidad de Los Andes, Santiago, Chile.
María Jesús ArayaCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Nicole JeraldoCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Constanza ArosCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Francisca TroncosoCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Daniela PobleteFacultad de Odontología, Universidad de Chile, Santiago, Chile.
Angela CourtCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Alexander OrtloffDepartamento de Ciencias Veterinarias y Salud Pública, Facultad de Recursos Naturales, Universidad Católica de Temuco, Temuco, Chile.
Jose BarrazaDepartamento de Ciencias Veterinarias y Salud Pública, Facultad de Recursos Naturales, Universidad Católica de Temuco, Temuco, Chile.
Francesca VelardeCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Carlos FarkasLaboratorio de Investigación en Ciencias Biomédicas, Departamento de Ciencias Básicas y Morfología, Facultad de Medicina, Universidad Católica de la Santísima Concepción, Concepción, Chile.
Claudio CarrilLaboratorio de Neuroinmunología, Facultad de Medicina y Ciencia, Universidad San Sebastián, Sede Concepción, Chile.
Noymar Luque-CamposCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Gonzalo AlmarzaLaboratorio de Fisiología y Bioenergetica Celular, Pontificia Universidad Católica de Chile, Santiago, Chile.
Maximiliano BarahonaDepartamento de Ortopedia y Traumatología, Hospital Clinico Universidad de Chile, Independencia, Chile.
Jose MatasCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Lucas CerecedaCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Rocío LorcaCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Jorge ToledoRed de Equipamiento Científico Avanzado-REDECA, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Karina OyarceLaboratorio de Neuroinmunología, Facultad de Medicina y Ciencia, Universidad San Sebastián, Sede Concepción, Chile.
Rolando VernalFacultad de Odontología, Universidad de Chile, Santiago, Chile.
Andrés CaicedoUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud e Instituto de Investigaciones en Biomedicina iBioMed, Escuela de Medicina, Quito, Ecuador-Mito-Act Research Consortium, Quito, Ecuador.
Andrea Del CampoLaboratorio de Fisiología y Bioenergetica Celular, Pontificia Universidad Católica de Chile, Santiago, Chile.
Yessia HidalgoCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile.
Roberto Elizondo-VegaLaboratorio de Biología Celular, Departamento de Biología Celular, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.
Farida DjouadIRMB, Université de Montpellier, INSERM, Montpellier, France.
Maroun KhouryCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile. mkhoury@uandes.cl.
Fernando E FigueroaCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile. ffigueroa@uandes.cl.
Patricia Luz-CrawfordCenter of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, Santiago, Chile. pluz@uandes.cl.ORCID 0000-0003-0067-7743

Funding

Agencia Nacional de Investigación y Desarrollo #FB210024
6 · The paper itself

Abstract

objectiveThe inflammatory responses from synovial fibroblasts and macrophages and the mitochondrial dysfunction in chondrocytes lead to oxidative stress, disrupt extracellular matrix (ECM) homeostasis, and accelerate the deterioration process of articular cartilage in osteoarthritis (OA). In recent years, it has been proposed that mesenchymal stromal cells (MSC) transfer their functional mitochondria to damaged cells in response to cellular stress, becoming one of the mechanisms underpinning their therapeutic effects. Therefore, we hypothesize that a novel cell-free treatment for OA could involve direct mitochondria transplantation, restoring both cellular and mitochondrial homeostasis.

methodsMitochondria were isolated from Umbilical Cord (UC)-MSC (Mito-MSC) and characterized based on their morphology, phenotype, functions, and their ability to be internalized by different articular cells. Furthermore, the transcriptional changes following mitochondrial uptake by chondrocytes were evaluated using an Affymetrix analysis, Lastly, the dose dependence therapeutic efficacy, biodistribution and immunogenicity of Mito-MSC were assessed in vivo, through an intra-articular injection in male C57BL6 mice in a collagenase-induced OA (CIOA) model.

resultsOur findings demonstrate the functional integrity of Mito-MSC and their ability to be efficiently transferred into chondrocytes, synovial macrophages, and synovial fibroblasts. Moreover, the transcriptomic analysis showed the upregulation of genes involved in stress such as DNA reparative machinery and inflammatory antiviral responses. Finally, Mito-MSC transplantation yielded significant reductions in joint mineralization, a hallmark of OA progression, as well as improvements in OA-related histological signs, with the lower dose exhibiting better therapeutic efficacy. Furthermore, Mito-MSC was detected within the knee joint for up to 24 h post-injection without eliciting an inflammatory response in CIOA mice.

conclusionCollectively, our results reveal that mitochondria derived from MSC are transferred to key articular cells and are retained in the joint without generating an inflammatory immune response mitigating articular cartilage degradation in OA, probably through a restorative effect triggered by the stress antiviral response within OA chondrocytes.

Indexed as

ChondrocytesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMice, Inbred C57BLMitochondriaOsteoarthritisAnimalsHumansMaleMiceUmbilical CordBiodistributionImmuno-safetyMesenchymal stromal cellsMitochondria transplantationMurine OA modelOsteoarthritis

Identifiers

PMID39773289
PMCPMC11706173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.